Sperm Banking
Total Page:16
File Type:pdf, Size:1020Kb
17 Sperm Banking Rakesh Sharma, Alyssa M. Giroski, and Ashok Agarwal What Is Sperm Banking Autologous and Donor Sperm or Fertility Preservation? Banking for Infertility History of Sperm Banking—50 Years Later Users of sperm banking can be divided into two categories: autologous or autoconservation and donor groups. The autocon- Cryopreservation of human spermatozoa is critical when it comes servation group includes patients who preserve their sperm or to preserving male fertility. While sperm cryopreservation, more testicular tissue for purposes of their own future fertility treat- commonly referred to as sperm freezing or sperm banking, has ment. The donor group includes men who are recruited to serve been prevalent in the scientic community in the treatment of as surrogate fathers to partners of couples suffering from refrac- infertile couples since the 1970s, the origins of sperm cryopreser- tory male infertility problems or for single women planning for vation dates back to as far as the 1660s when Lazzaro Spallanzani a child with donor sperm. These donors elect sperm banking for found that sperm could maintain motility under cold conditions potential use in assisted reproductive techniques (ART). using the invention of Leeuwenhoek’s microscope [1]. Sperm cryopreservation came to be a forerunner in scientic studies after the development of articial insemination and the grow- ing need for longer-term storage of bull sperm in the US dairy Sperm Banking in Patients with Cancer industry in the late 1950s to early 1960s. This period of time saw signicant growth in the studies on sperm biology, morphology, In the United States, up to 9.2% of patients diagnosed with cancer and cryobiology [2]. are younger than 45 years of age, and 1.1% of males are younger The advancement in sperm cryopreservation began in 1949 with than 20 years [3]. Patients with cancer of the reproductive age the use of glycerol, a permeant that could protect spermatozoa group are most commonly referred to sperm banks in the United at low temperatures. In 1953, the rst reported live human birth States and comprise about 44% of all referrals [4]. Testicular can- using thawed sperm was reported. The spermatozoa were stored cer—both seminoma and non-seminoma—is the most common temporarily in dry ice before being thawed and used for arti- oncologic diagnosis in the reproductive age group. Other can- cial insemination. However, the introduction of liquid nitrogen cers include Hodgkin’s disease, non-Hodgkin’s lymphoma, and soft-tissue tumors such as sarcomas. A high incidence of poor (LN2) in 1964 paved way for the opening of the rst therapeutic sperm bank located in Iowa. Although modern storage methods semen quality, most commonly asthenozoospermia, is reported in men with cancer (64.2%–86.3%) [5,6]. Other semen abnor- use liquid nitrogen vapors, the development of LN2 allowed for long-term storage that can be carried out for decades and can still malities among patients with cancer who are referred to sperm result in successful fertility outcomes. banking include oligozoospermia (49.8%–53%) [7–9], severe oli- gozoospermia (22.6%) [8], and azoospermia (9.7%–21%) [7–9], and teratozoospermia is the most common abnormality (93.2%) among pretreatment cancer patients [6]. Indications for Sperm Banking Testicular cancers have local and systemic inuences on sper- There are many medical conditions where sperm banking is matogenesis because of their relationship to local paracrine fac- indicated to preserve fertility. Patients with cancer are the tors such as β-human chorionic gonadotropin (β-hCG) [10] and most common group of men who are referred for sperm cryo - cytokines [11]. Malignancy may disrupt the blood-testis barrier preservation. Chemotherapy and radiotherapy are highly toxic resulting in antisperm antibodies [12]. Reports suggest that tes- to the reproductive system, leading to temporary or perma - ticular cancer and male infertility is a result of testicular insults nent azoospermia or oligozoospermia. Patients with medical culminating into testicular dysgenesis syndrome [13]. This the- conditions such as lupus, multiple sclerosis, urological dis - ory is supported by a high incidence of carcinoma in situ (CIS) eases such as varicocele, testicular torsion, spinal cord injury, that is common in testicular biopsies from infertile men. CIS can and ejaculatory dysfunction can also benet from sperm transform into invasive cancer in 50% of cases [14,15]. Some of cryopreservation. the systemic effects of cancer include fever, malignancy-related 167 168 Male Infertility in Reproductive Medicine malnutrition, abnormal immune response, altered hormonal In a retrospective study of 4,345 adults and young adoles- milieu, and a generalized stress and inammatory response. cents from 23 French regional sperm banks afliated with the This results in increased production of cytokines such as inter- CECOS network, Daudin et al. (2015) reported that 93% of the leukins (ILs) and tumor necrosis factor (TNF), all of which subjects successfully provided a semen sample by masturba- can have devastating consequences on testicular and sperm tion, and sperm from 3,616 patients (83%) were frozen [28]. function [16,17]. This may also result in chromosomal aneu- These numbers were similar to smaller patient series; 84% ploidy in the germ cells and sperm damage even prior to cancer (n = 25) from Muller et al. (2000) [38], 83.7% (n = 80) from Van treatment [18]. There is no relationship between the severity of Casteren et al. (2008) [39] and 86.1% (n = 238) from Bahadur male infertility and the stage of the malignancy. Therefore, it is et al. (2002) [40]. Daudin et al. also reported an increase in the important that oncologists address each cancer patient’s risk of number of young adolescents (<15 years) who opted for sperm fertility irrespective of the clinical diagnosis or the stage of the cryopreservation [28]. They attributed this increase largely to disease [19,20]. improved life expectancy owing to effective treatment, greater Therapeutic agents used to treat cancer have varying degrees awareness of sperm banking options before cancer treatment of impact on spermatogenesis. The effect on spermatogenesis and also to greater awareness among the different medical is dependent on sperm quality before treatment, type of malig- teams including oncologists and reproductive medicine and nancy, drug characteristics, treatment regimen, and patient sus- infertility specialists. ceptibility. Therefore, it is not possible to predict whether an individual patient will become permanently azoospermic, or whether they will regain partial to complete spermatogenesis after treatment [4,21–23]. For this reason, the Ethics Committee Challenges in Sperm Banking in of American Society for Reproductive Medicine (ASRM; 2013) Adolescents Diagnosed with Cancer and the American Society of Clinical Oncology (ASCO) [24] recognizes the importance of addressing the issue of fertility Signicant challenges were observed in various surveys con- preservation and course of treatment in men diagnosed with can- ducted in the United States, Australia, and New Zealand. cer. Both these societies recommend that clinicians discuss the A Canadian survey showed that only 17.8% of male adolescents potential gonadotoxic impact of cancer treatment and fertility and young adults used fertility preservation options between preservation options with their patients. 1995 and 2000. This was largely attributed to inadequate infor- Currently, sperm banking is the most effective way to preserve mation on sperm banking options [41]. Similarly, a survey from reproductive potential in adult or postpubertal adolescent male a North American center showed that only 28.1% of patients ages patients with cancer for its subsequent use with assisted repro- 13 years and older banked sperm [42]. Some of the barriers pre- ductive procedures [25,26]. It is a simple and effective way of venting young adolescents from sperm banking were urgency of preserving fertility potential even in patients with cancer and treating cancer, oncologist’s anxiety about discussing fertility poor sperm characteristics [27]. and sexuality with young adolescents, poor prognosis, cost, and difculty in nding sperm banking facilities [43]. Sperm Banking in Adolescents with Cancer Ethical and Legal Challenges The incidence of cancer in adolescents has increased in the last three decades; however, the survival rates have also signicantly The intersection of cancer and fertility raises many ethical issues improved [28]. Sperm banking is a viable reproductive option for oncologists and fertility specialists. Cancer management is a available to young adolescents who wish to establish biological stressful period for young patients and their parents. The option paternity in the future. The ASRM and the ASCO support the of a more conservative oncologic treatment and the chance to practice of sperm banking in these patients. However, sperm preserve fertility is a difcult choice that carries its own risks banking is not available in all pediatric oncology centers and and uncertainties. The oncologist therefore has an integral role very few adolescent-friendly facilities are available [29,30]. in not only providing the best treatment options, but he must also Adolescents 12 years or older should be offered an opportunity to be aware of current fertility preservation options available to freeze their sperm prior to the start of their treatment [31]. In cases younger adolescents who may